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· B16 cells produce a tumor facilitating factor (TFF) that 
increases Bl6 tumor incidence in mice injected With a 
small number of Bl6 cells. TFF was derived from serum-
free culture supernatant concentrated on an Amicon 
PMlO membrane. One milliliter of concentrated material 
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represented the product lOx B16 cells during a 6-h incu-· 
bation. We report data that indicate TFF may act by 
altering macrophage function. In the nude mouse defi-
cient in T cell, but not macrophage function, the injection 
of 0.8 ml of TFF facilitated tumor development. Subcu-
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taneous injection of 0.7 ml of TFF induced mouse peri-
toneal macrophages to spread when removed and plated 
on glass coverslips. This effect peaked 3 days after injec-
tion of TFF and was abrogated by heating the TFF to 
70 °C for 1 h. The injection ofTFF was also able to induce 
macrophage spreading in nude mice. Injection of viable 
B16 cells induced spreading, as would be predicted if 
TFF is produced by Bl6 cells in vivo. In vitro incubation 
of peritoneal cells with TFF was also able .to induce 
macrophage spreading. Finally, subcutaneous injection 
of TFF reduced by 80% the accumulation of peritoneal 
cells in response to intraperitoneal injection of phyto-
hemagglutinin. We suggest that one mode by which TFF 
facilitates tumor growth is by reducing the numbers of 
macrophages chemotaxing to the tumor site. 
B16 melanoma cells produce a factor that facilitates tumor 
development from a threshold inoculum of viable B16 cells 
[1]. This tumor facilitating factor (TFF) is present in frozen-
thawed B16 cells grown in vitro or harvested from tumors. The 
TFF activity is removed from intact B16 cells by trypsin treat-
ment prior to freeze-thawing, suggesting that it is a surface 
protein. TFF is also secreted into culture medium. Using tumor 
incidence as an assay it was found that TFF from culture 
medium is not sedimented by centrifuging at 100,000 g for 1.5 
h and it is not dialyzable. TFF does not alter the rate of tumor 
appearance and it is not stimulatory of B16 growth in vitro. 
This suggests that TFF does not act directly on the B16 cells 
by increasing growth rate. 
Numerous reports have appeared suggesting that tumor cells 
actively evade host defenses by elaboration of immunosuppres-
sive factors. Neoplastic cells produce factors that inhibit lym-
phocyte function as measured by mitogen response [2,3], cyto-
toxicity [ 4,5], and plaque forming cell response [6, 7]. These 
activities have been found in sera [3, 7], ascites fluids [ 4, 8, 9], 
and tumor homogenates [6]. Tumors and tumor-derived mate-
rials also interfere with macrophage function as measured by 
Listeria resistance [10], delayed hypersensitivity response [11-
13], and chemotaxis both in vivo [14-16], and in vitro [17, 18]. 
Tumor-derived factors have also been reported to increase 
tumor incidence [19] and stimulate macrophage migration 
[20). 
. In this paper we report studies on the mechanism of TFF 
action. It was found that TFF facilitates B16 tumor develop-
ment in BALB/c nude mice that are deficient in mature T-cell 
function. Peritoneal cells· taken from C57B1/6J mice or from 
BALB/c nude mice injected with TFF exhibited increased 
spreading. Macrophage spreading was also induced by the 
injection of viable B16 cells. In vitro treatment of adherent 
peritoneal cells with TFF was able to induce macrophage 
spreading. TFF was also shown to inhibit in vivo chemotaxis, 
as measured by accumulation of peritoneal cells in response to 
i.p. injection of phytohemagglutinin (PHA.). It is suggested that 
TFF facilitates tumor development by inducing macrophage 
spreading, immobilizing the macrophage, and reducing its che-
motaxis to the tumor site. 
MATERIALS AND METHODS 
Mice 
Female C57B1/6J mice greater than 10 weeks of age were used for 
all experiments. The mice were obtained from J ackson Laboratories, 
Bar Harbor, Maine. 
BALB/c nude (nu/ n.u) congenitally athymic mice were obtained 
from Charles River Laboratories, Boston, Massachusetts. They were 
mainta ined under pathogen-free conditions and appeared healthy at 
the completion of the experiments. 
B16 Melanoma 
B16 melanoma arose spontaneously in a C57B1/6J mouse at Jackson 
Laboratory. The B16 cells used in these experiments were adapted to 
t issue cul ture and cloned in our laboratory from a tumor-bearing 
C57B1/ 6J mouse obtained from Dr. J. C. Bystryn (New York Univer-
sity Medical Center). Our laboratory's line is deeply pigmented whether 
growing · in vivo or in vitro. In ou r experience a B16 tumor never 
regresses and is a lways lethal. B16 cells were maintained in monolayer 
cultures using RPMI 1640 medium (GIBCO, Grand Island, New York) 
supplemented with 5% fetal calf serum (FCS) (Microbiological Associ-
ates, Bethesda, Maryland) , streptomycin 100 1-'g/ ml, and penicillin 100 
U/ ml. Cells were passaged approximate ly twice a week using 0.5% 
trypsin in phosphate-buffered saline (PBS) to detach cells from cu lture 
flasks. Deta ils of preparing frozen-thawed B16 cells were described 
previously [1]. 
Bl6 Culture Supernatants 
Culture supernatant was prepared by a modification of the method 
previously published [1). Cultu res in RPMI 1640 with 5% heat-inacti-
vated FCS were grown to confluency in 960 em" roller bottles (Corning) . 
These roller bottles contained approximately 2.5 X 10" cells. The 
medium was decanted and the bottles were washed 3 times with PBS. 
Fifty milliliters of serum-free RPMI 1640 was added to each bottle and 
the bottles were incubated 6 h at 37°C. The serum-free supernatant 
was collected and 150 ml of RPMI containing 1% FCS was added to 
each bottle for overnight incubation. The following day the bottles 
were aga in washed with PBS and incubated with serum-free RPMI 
1640. Five such harvests could be obtained from a confluent bottle. The 
pooled serum-free supernatants were then concentrated 20-fold on an 
Amicon PM10 membrane (Amicon Corp. , Lexington, Massachusetts) 
with an exclusion weight of 10,000 daltons. The material was then 
centrifuged at 100,000 g for 1.5 h and exhaustively dialyzed against PBS 
before sterilization by ftltra t ion through a 0.20-mm filter (Millipore 
Corp ., Bedford, Massachusetts) . Protein concentration was determined 
by the method of Lowry et a l. [21). 
Standard Assay for TFF Activity 
TFF has been defined as a molecule(s) that increases the frequency 
of tumor takes to an inoculum of viable B16 tumor cells. The assay for 
TFF activity involves challenge of C67Bl/6J female mice with viable 
B 16 cells in one flank and material suspected of having TFF activity or 
diluent material in the opposite flank. For this assay viable B16 cells 
are obtained from tissue culture. Those adherent are removed from the 
culture flasks by gentle trypsin. 
Macrophage Spreading Assay 
The macrophage spreading assay was modified from that published 
by Bianco et al [22). Unstimulated peritoneal cells were harvested from 
C57B1/6J female mice by the injection of 6.0 ml of RPMI 1640 with 5% 
FCS. All FCS was heat inactivated at 56°C for 1 h. The cells were 
centrifuged and resuspended to 5 X 10'' cells/ ml in RPMI 1640 with 5% 
FCS, and 150 fil was pipetted onto each 12-mm circular glass coverslip 
(Propper). Coverslips were arranged 4 per 75-mm Petri dish. One Petri 
dish was used per group. The coverslips were incubated for 10 min at 
37°C, and washed 3 times with PBS. The PBS was aspirated off and 5 
ml of RPMI 1640 was added to each Petri dish. The Petri dishes were 
then incubated for an additional 60 min at 37°C in the presence of 5% 
C02• The media was aspirated off and the cells were fixed with 2.5% 
gluteraldehyde in PBS. One hundred cells from random fields were 
examined on each coverslip with a phase contrast microscope to deter-
mine the percentage of cells spread. 
Macrophage Phagocytosis Assay 
Each treatment group consisted of four glass coverslips in wells of 
Linbro FS24 trays. Sheep erythrocytes (E) were opsonized with IgG 
(obtained from Cordis) and complement (C). Erythrocytes were added 
to IgG, incubated 37°C for 15 min, and washed twice wi th PBS. Fresh 
mouse serum (0.2 ml) was added to 1 ml of a 5% suspension of ElgG 
and 0.8 ml of PBS. The suspension was incubated 10 min at 37°C. Cold 
PBS was added a nd the cells were washed twice in PBS and resus-
pended in Oulbecco's medium to a 0.5% suspension. Unstimulated 
peritoneal cells were obtained from C57B1 / 6J female mice, washed 
with PBS, and resuspended in Dulbecco's medium with 10% FCS to 10,; 
cells/ mi. The ceLls were plated 10''/covers\ip, incubated at 37°C for 30 
min, and washed with Dulbecco's medium. Opsonized erythrocytes 
(ElgGC') were resuspended to a 0.05% suspension in Dulbecco's me-
dium and added (0.25 ml) to the coverslips. TFF was also added in the 
designated quan tities. The coverslips were incubated for 60 min at 37°C 
in 5% C02, then washed with PBS. Noningest.ed erytlu-ocytes were 
lysed by the addition of PBS:H20 (1:4) for 5 s. The coverslips were 
then washed with PBS and fixed with 2.5% glutaraldehyde in PBS. One 
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hundred cells were examined on each coverslip and both phagocytic 
and spread cells were enumerated. 
RESULTS 
Dose R esponse of a B16 Culture Supernatant in C57Bl/6J 
Mice 
Culture supernatant prepared as described was assayed for 
facilitating activity using the standard assay. The data indicate 
that the frequency of tumor takes to a fixed inoculum of viable 
Bl6 cells can be altered by simultaneous challenge with TFF-
containing preparations. The extent to which TFF increases 
the frequency of tumor takes is directly dose dependent. For 
the sake of comparison, the fac ilita ting capacity of TFF ob-
tained by freeze-thaw killing of tissue culture B16 cells har-
vested with EDTA is shown (Fig 1). 
Effects of TFF on Tumor Incidence in BALB/c Nude Mice 
In order to decern whether TFF activity was dependent on 
a mature T-cell system, TFF concentrated as described was 
tested for its effect on Bl6 tumor initiation in congenitally 
athymic mice. The ability of frozen-thawed B16 cells to increase 
Bl6 tumor incidence in BALB/c nude mice was also tested. 
These frozen-thawed Bl6 cells were grown in vitro and har-
vested with EDT A. They were shown previously to have TFF 
activity in C57B1/6J mice (1). BALB/c nude mice (Charles 
River) were injected s.c. in the right flank with 7 X 10'' B16 
cells in 0.2 ml of complete medium PBS; 0.8 ml of TFF or 5 X 
106 frozen-thawed B16 cells were injected in the left flank. Both 
frozen-thawed Bl6 cells and TFF increased tumor incidence 
compared to those mice that received PBS (Table I). 
In Vivo Effects of B 16 Culture Supernatant on Macrophage 
Spreading and L eukocyte Count 
Thirty-six C57Bl/ 6J female mice were placed into 9 groups 
of 4 mice each. On day 0, 4 control groups were injected s.c. 
with 0.8 ml of PBS and 4 experimental groups were injected s.c. 
with 0.8 ml of culture supernatants. One additional group 
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FIG L Dose response curve of TFF. C57Bl/ 6J mice were injected 
with 5 X tO' viable B16 cells in one fl ank and TFF, freeze-thawed Bl6 
cells, or RPM! (cont rol) in the opposite flank. 
TABLE I. Effect of fro zen-thawed B16 cells and TFF on B16 tumor 
incidence in BALB/c nude mice 
PBS 0.7 ml 
5 X 10" frozen-thawed 
Bl6 cells in 0.7 ml 
TFF0.8 ml 
Pe rcent of mice with tumors (group 
s ize) 
A 
33 (3) 
100 (5) 
8 
0 (20) 
20 (10) 
BALB/c nude mice (Charles River) were injected with 7 X 10" B16 
cells s.c. in the righ t flank and additional materials s.c. in the left fl ank. 
Mice were observed 59 days for tumor growth. A and B represent 
independent experiments. 
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FIG 2. Effect of in vivo treatment with TFF on peritoneal macro-
phage spreading. Each point represents 4 mice injected on day 0 with 
either PBS (controle- ---e), TFF (+-- +) ,or heat- inactivated TFF 
(•). Peritoneal ce lls were harvested on the indicated days and assayed 
for spreading. 
received 0.8 ml of culture supernatant that ha·d· been heated to 
70°C for 1 h. Each day for the next 4 days one control group 
and one culture supernatant-treated group was sacrificed. 
The group that received heated culture supernatant was 
sacrificed on day 2. Peritoneal cells were harvested by the i.p. 
injection of 5 ml of RPMI 1640-5% FCS. The peritoneal cells 
from each mouse were handled separately. The cells were 
centrifuged and resuspended in RPMI 1640 with 5% FCS to 5 
X 10" cells per ml. A macrophage spreading assay was performed 
as previously described. Approximately 100 Jll of blood was also 
drawn from the retroorbital plexus of each mouse on both day 
0 and the day of sacrifice. This required that the mice be 
anesthetized with ethyl ether. A leukocyte count was made 
after lysing the erythrocytes with 3% acetic acid and a differ-
ential count was made from a Wright-stained smear. 
The results of the spreading assays are shown in Fig 2 and 
the results of the leukocyte and differential counts are shown 
in Table II. 
The s.c. injection of Bl6 culture supernatant induced the 
peritoneal cells to spread in vitro. This effect was maximal on 
day 3 and lasted for 3 days. On day 2 there was a 50% drop in 
peripheral leukocyte count which was reversed by day 3. Lym-
phocyte count was depressed 48% and monocyte count 62%. 
Heating culture supernatant to 70°C for 1 h partially inacti-
vated it as measured by both spreading and leukocyte count. 
Effect of Concentrated B16 Culture Supernatant on 
Spreading of Macrophages from Nude Mice 
B16 culture supernatant increased B16 tumor incidence in 
both C57Bl/6J mice and BALB/c nude (congenitally athymic) 
mice. It also induced spreading of peritoneal macrophages 
removed from C57Bl/6J mice. This experiment was perfonned 
to determine whether Bl6 culture supernatant can also induce 
spreading of macrophages from nude mice. BALB/c nude mice 
were injected with either 0.4 ml of PBS or 0.4 ml of 40-fold 
concentrated B16 culture supernatant. Peritoneal cells were 
harvested 3 days later and spreading by glass adherent cells 
March 1983 EFFECT OF TUMOR FACILITATING FACTOR (TFF) ON MACROPHAGE FUNCTION 165 
TABLE II. Effect of injection of Bl6 culture supernatant on 
Peripheral leulwcyte counts 
WBC/ nun" x 10" (SO) 
OayO Day I Day 2 Day 2" Day 3 Oay4 
T ota l WBC 8.7 (2.4) 7.3 (1.4) 4.3 (1.9) 8.9 (0.9) 8.B (0.9) 8.9 (0.6) 
Lymphocytes 7.0 (0.6) 5.4 (0.3) 3.4 (0.3) 6.4 (0.5) 7. 1 (0.3) 7.0 (0.5) 
Monocytes 1.2 (0.4) 1.2 (0.5) 0.5 (0.2) 0.9 (0.2) 1.2 (0.6) 1.3 (0.3) 
Polymorphonu- 0.5 (0.3) 0.7 (0.5) 0.4 (0.2) 0.7 (0.3) 0.6 (0. 1) 0.6 (0.2) 
clear leukocytes 
These numbers are the tota l leukocyte and differential counts (W righ t's stain 
of the mice represented in Fig. 1. Day 0 values obta ined prior to chall enge with 
TFF. 
" Hea t-inactivated TFF (70°C for I h) 
was assayed on coverslips as previously described. There were 
4 mice per group . 
The injection of mice with B16 culture supernatant induced 
spreading in vitro by 34.7% of the adherent peritoneal cells, 
whereas 61% of adherent cells spread from mice injected with 
PBS (Table III) . Thus, B16 culture supernatant was able to 
induce spreading of macrophages from nude athymic mice. 
Effect of Injection of B16 Cells on Peritoneal Macrophage 
Spreading 
It is believed that B16 cells produce TFF in vivo. Since 
injection of TFF preparations caused peritoneal macrophages 
to spread, it was hypothesized that t he injection of viable B16 
cells shou ld have a similar effect. The induction of spreading 
following B16 culture supernatant injection had a dmation of 
3 days. In t his experiment the kinetics of macrophage spreading 
were studied in mice that either developed tumors or fa iled to 
do so. Mice were injected with 3 doses of B16 cells: a high dose 
capable of producing tumors in 100% of mice, a threshold dose 
that produces tumors in 20-60% of mice, and a dose that does 
not produce tumors. 
C57B1/ 6J female mice were injected s.c. with either 104 , 8 X 
10", or 10" viable B16 cells . Control mice were injected with 
PBS. There were 16 mice in each group. Four mice from each 
group were sacrificed on days 1, 3, 6, and 14. The peritoneal 
cells were removed and a spreading assay was performed as 
previously described. The cells from each mouse were handled 
separately and 3 coverslips were counted from each mouse so 
that each point represents the mean of 12 coverslips. There was 
no significant variation between groups in recovery of peritoneal 
cells. 
The resu lts are depicted in Fig 3. The injection of 10", 8 X 
10", or 106 B16 cells induced significant peritoneal ~ell spreading. 
The injection of 106 B16 cells had the greatest effect on days 1-
6. On day 6 a dose response was seen with the higher doses of 
cells producing the most spreading. By day 14 the response to 
104 and 10'; cells had dropped considerably, bu t little change 
was seen in the response to 8 X 104 ce!Js. Those mice that 
received 106 cells had tumors on day 14. The average tumor 
measurements were 1.0 X 0.5 em. No other mice had tumors. 
From prior experience it can be expected that 20-60% of the 
mice injected with 8 X w·• cells would develop tumors, but no 
mice injected with 104 cells would develop tumors. 
In Vitro Effects of B1 6 Culture Supernatant on Macrophage 
Spreading 
Unstimulated adherent peritoneal cells from C57B1/ 6J fe-
male mice were incubated in vitro with 20-fold concentrated 
B16 culture supernatant to determine whether an effect on 
macrophage spreading could be observed similar to that ob-
tained by in vivo treatment with culture supernatant. The 
spreading assay was performed as previously described with the 
exception that adherent peritoneal cells on coverslips were 
incubated for 60 min at 37°C with varying a mounts of culture 
supernatant. It was found that in vitro incubation with culture 
supernatant resulted in doubling of the percentage of cells 
TABLE III. Effect of concentrated Bl6 culture supem atant on 
spreading of m.a.cropha.ges from nude mice 
Mate ria ls injected s.c. % Spread ing (SEM) 
PBS 0.4 ml 34.7% (6.4) " 
Bl6 cul ture supernatant 0.4 ml 61.0% (5.2) 
BALB/c nude mice were injected s.c. with either PBS or 40-fold 
concentrated Bl6 cul ture supernatant. There were 4 mice per group. 
Peritoneal ce lls were har vested 3 days later and spreading by glass 
adheren t ce lls was determined . 
0' 
c 
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"p < 0.05 as determined by t-test on difference between means. 
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FIG 3. Effect of B 16 cells on peritoneal macrophage spreading. Each 
point represents 4 mice injected on day 0 with either PBS, 10', 8 x 10"', 
or Bl6 cells. Peritoneal cells were harvested on t he indicated days and 
assayed for spreading. 
spread (Table IV) . The optimal concentration of culture super-
natant varied 1.0-0.5 mg/ ml depending upon t he preparation. 
The dose-response curve was biphasic. A reduction in spread ing 
was observed with doses less than or greater than the optimal 
dose. 
Effects of B16 Culture Supernatant on Macrophage 
Phagocytosis 
B16 culture supernatant was found to inhibit macrophage 
spreading at supraoptimal concentrations (Table IV). It was 
necessary to determine whether this inhibition was caused by 
toxicity. Macrophage phagocytosis of ElgGC' was measured 
with varying concentrations of cultm e supernatant present to 
determine the effect ofTFF on macrophage viability. Spreading 
of the phagocytic cells was also recorded. It was found (Table 
V) that while concentrations of culture supernatant in the range 
0.25-5.0 mg/ ml had no significant effect on macrophage phag-
ocytosis, the degree of spreading varied 37.7-15.3%. Thus, con-
centrations of B16 culture supernatant that are supraoptimal 
for macrophage spreading do not inhibit phagocytosis and 
presumably are not toxic for macrophages. 
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TABLE IV. Macrophage spreading induced by in vitro treat1 wnt 
with B 16 culture supernatant 
% Spreading 
:X (SEM) 
RPMI 1640 a lone 9.8% (0.6) 
TFF 0.10 !Lg/ml 6.7% (1.0) 
TFF 0.25 !Lg/ml 7.7% (0.6) 
TFF 0.5 !Lg/ ml 9.8% (1.6) 
TFF 1.0 !Lg/ ml 17.2% (3.2) 
TFF 3.0 !Lg/ ml 11.0% (1.4) 
TFF 10.0 !Lg/ml 4.0% (1.2) 
TFF 30.0 !Lg/ ml 7.2% (1.4) 
G lass ad herent peritoneal ce lls from C57Bl/6J female mice were 
incubated at 37° for 1 h on coverslips with TFF from B16 culture 
supernatant concentrated 20-fo ld. Each group represents 4 coverslips. 
TABLE V. E ffect of concentrated B16 culture supernatant on 
macrophage phagocytosis of E lgGC' 
erythrocytes not opsinized 
ElgGC' 
EigGC' + TFF 0.25 !Lg/ml" 
ElgGC' + TFF 0.50 !Lg/ ml 
EigGC' + TFF 1.0 !Lg/ ml 
ElgGC' + TFF 5.0 !Lg/ ml 
% of Cells in-
gesting ElgGC' 
(SEM) 
0% 
77.7% (20) 
74.0% (3.5) 
81.7% (3.3) 
77.8% (4.8) 
79.0% (2.6) 
% of Phagocytic 
cells that spread 
(SI':M) 
18.7% (1.3) 
22.5% (2.4) 
37.7% (6.0)" 
22.0% (3.0) 
15.3% (1.3) 
G lass adherent peritoneal cells from C57Bl/6J female mice were 
incubated for 1 h on coverslips in t h e presence of sheep erythrocytes 
(E) opsonized with IgG and mouse complement (ElgGC'). TFF was 
added as indicated . Both phagocytic and s pread ce lls were enumerated. 
Each number is the .mean of 4 covers lips (SEM). 
" TFF = 20-fo ld con centrated B16 culture supernatant. 
"p < 0.05 by t-test on difference between means. 
Effect of Frozen-Thawed B16 Cells on Peritoneal Cell 
Accumulation in Response to PHA 
It was postulated that the effects of TFF preparations on 
macrophage spreading and leukocyte count may result in re-
duced in vivo chemotactic response. C57B1/6J female mice 
were injected s.c. on day 0 with either RPMI 1640 or frozen-
thawed B16 tumor cells. The frozen-thawed B16 cells were 
derived from teased tumors. Frozen-thawed B16 tumors were 
previously [1] found to have TFF activity. On day 1, mice 
received an i.p. injection of 2.0 ml of a 500-fold dilution of PHA-
p (Difco) . All mice were sacrificed ori day 3, and 5 ml of RPMI 
1640 was injected i.p. The abdomens were vigorously massaged, 
the fluid was withdrawn and the cells were counted. It was 
found that the s.c. injection of 2 X 107 frozen-thawed B16 cells 
decreased the response to PHA by 80% (Table VI). The injec-
tion of 2 X 106 frozen-thawed B16 cells produced less inhibition. 
The s.c. injection of 2 x 107 B16 cells that were treated with 
0.5% trypsin for 2 min prior to being frozen-thawed had only a 
slight inhibitory effect on peritoneal cell accumulation. 
DISCUSSION 
B16 cells produce a factor(s) that increases B16 tumor inci-
dence when injected into mice together with viable B16 cells. 
This ability to increase tumor incidence is termed tumor facil-
itation and the factor(s) is referred to as tumor facilitating 
factor (TFF). The action of TFF in mice is systemic [1). The 
extent to which TFF facilitates B16 tumor takes is directly dose 
related. In addition, TFF does not stimulate B16 growth in 
vitro. For these reasons, it is postulated that TFF alters the 
interaction between the B16 cells and the host, possibly by 
interfering with the immune response. Evidence supporting this 
hypothesis is presented in this paper. 
The ability of TFF to facilitate B16 tumor development in 
BALB/c nude mice indicates that TFF action is not dependent 
upon mature T-cells. Inasmuch as TFF activity is dose depend-
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TABLE VI. Effect of fro zen-thawed BI6 cells on peritoneal cell 
accumulation in response to P HA 
Injected Peritonea l cells/ml day 3 Injected s.c. i.p. (mean± SEM) Day 0 Day 1 A B c 
RPM! 1640 8.97 X 10" (1.13) 9.0 (0.5) 6.4 (1.0) 
RPM! 1640 PHA 16.5 X I O'' (3.07)" IG.l (2.5) 11.4 (0.4 )" 
2 x 107 FT Bl6 PHA 10.5 X 10'' (1.77) 7.7 (2.5) 5.5 (0.6) 1' 
2 x 10" FT BHi PHA 12.6 X 10" ( 1.21) 13.9 (1.0) 
2 X 107 FT Bl6 PHA 14 .4 X 10'' (4.9) 
trypsin 
On day l , C57B I/ 6J female mice were injected s.c . with either RPM! 1640 or 
frozen- thawed Bl6 tumor cells. On day I, Groups 2-5 we re injected i.p. with 2.0 
ml of PHA-P (Difco) diluted 500 times. On day 3 mice were sacrificed and 
peritoneal exudate cells were counted. A, B, and C represent independent exper-
iments. Significance was dete rmined by I- test on difference between means. A, n 
= 4; B and C, n = 5. 
"Line 2 is sign ificantly different from line I (p < 0.05). 
1
' Line 3 is sign ificantly different from line 2 (p < 0.05). 
ent, the magnitude of the demonstrated effect in nude mice 
may be more a matter of the dose of TFF chosen rather than 
any differences between nude and normal mice. However, as 
the threshold dose of viable B16 cells in the BALB/c nude 
mouse is 1 log lower than the syngeneic C57 mouse, a mature 
T-cell system probably plays some role in determining tumor 
takes. It should be remembered that nude mice are known to 
have non-T-cell tumor defenses (24], including natural killer 
(NK) cells [25] and macrophages [26]. While either of these 
systems may be the target of TFF action, prior experiments 
indicate TFF is active in C57B1/6J mice over the age of 12 
weeks, and therefore lacking detectable levels of spontaneous 
NK activity (27]. This suggested that TFF action may be 
directed against macrophage. 
The effects of TFF on macrophage function were investi-
gated. It was found that the injection of mice with a dose of 
TFF known to facilitate tumor development caused the peri-
toneal cells to spread when removed and placed on coverslips. 
A similar effect on macrophage spreading was seen when ad-
herent peritoneal cells were treated in vitro with TFF. In 
addition, the injection of frozen-thawed cells inhibited in vivo 
chemotaxis measured by accumulation of peritoneal cells in 
response to i.p. PHA. This in vivo chemotaxis assay has been 
well characterized by Snyderman and coworkers [15,17] and 
the responding cells after 2 days are almost entirely monocytes 
and lymphocytes. 
The effects of TFF on macrophages cannot be attributed to 
such artifacts as FCS or endotoxin. All FCS that came in 
contact with either peritoneal cells, TFF, or B16 cells was first 
heat inactivated at 56°C for 1 h. It was reported by Bianco et 
al [22) that this is sufficient to prevent the generation from 
plasma of macrophage spreading activity. Heat-inactivated FCS 
was found not to have any effect on either macrophage spread-
ing or tumor incidence (unpublished data) . TFF activity was 
found to be sensitive to 70°C for 1 h. It is well accepted that 
these conditions are not sufficient to inactivate endotoxin . 
It is theorized that TFF facilitates tumor development as a 
consequence of the induction of macrophage spreading. This 
immobilizes the macrophages, thus reducing or inhibiting che-
motaxis. The nude mouse experiments demonstrated that T 
cells are not required for tumor facilitation, and the in vitro 
macrophage spreading assay showed that TFF can act directly 
on adherent cells. Both induction of macrophage spreading and 
inhibition of chemotaxis were demonstrated in mice treated 
with TFF. Macrophage spreading was also found to correlate 
well with tumor facilitation. It is well documented that macro-
phages are potential effector cells in tumor resistance. Inhibi-
tion of macrophage chemotaxis may logically account for at 
least some tumor facilitation. 
Tumor products that inhibit macrophage chemotaxis both in 
vitro and in vivo have been previously described by Snyderman 
et al [17] and others [13,14]. However, the mechanism of this 
inhibition has not been reported. These data suggest that 
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chemotaxis is inhibited as a consequence of increased macro-
phage spreading. Macrophage spreading is known to be one 
step of a series which leads to complete macrophage activation 
[28]. What this theory suggests is that TFF init iates an early 
phase in the sequence of macrophage activation and thereby 
immo bilizes them. T his results paradoxically in facilitation of 
tumor development. 
Various degrees of macrop hage activation have been defined. 
Thiolglycollate-activated macrophages, will spread rapidly bu t 
are not tumoricidal unless incubated with endotoxin (29]. How-
ever, macrophages stimulated with BCG, MAF, Toxoplasma 
gondii, or Corynebacterium paruum are cytotoxic to tumor 
cells including Bl6 [29- 32]. T hiolglycollate-induced peri toneal 
macrophages enhance B l 6 tumor development when injected 
s.c. with an inoculum of B l 6 cells (32]. While t he exact level to 
which T FF activates the macrophage is yet to be determined, 
there is a precedent for partial activation of t he macrophages. 
It is not proved that the TFF and the macrophage spreading 
activity a1·e t he same molecule. However , there is a strong 
correlation between macrophage spreading and tumor facili ta-
tion. Both activi ties ar e systemic, and both are effective in nude 
mice. Tumor facilitation, inhibit ion of macrophage accum ula -
tion, and macrophage spread ing m·e all induced by the same 
dose of material. In addi tion, the activit ies are present in both 
Bl6 culture supernatant and B l6 tumor homogenate. T he dose 
response curves for both tumor facilitation in vivo, and macro-
phage spreading in vitro show a supraoptimal range, in which 
the effects of these activit ies are reyersed. Supraopt imal con-
centrations of T FF are not toxic to macrophages in vitro as 
measured by phagocytosis of sheep erythrocytes. F inally, the 
injection of viable Bl6 cells was previously [1] found to fac ili tate 
the development of tumors at distant sites. Macrophage spread-
ing was also induced under t hese condi tions. T hus, both TFF 
and macrophage spreading activi ty ar e produced by Bl6 cells 
in vivo. Although it is not proved that TFF and macrophage 
spreading activity are the same molecule, the correlation be-
tween these activities is strong. 
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